menu-iconMore mobile-close-icon
Skip Navigation
Skip Navigation
PrintDownload PDFGet Adobe ReaderDownload to WordDownload as HTMLDownload as XMLCitation Manager
Save to Favorites
Measure Summary
Title
Schizophrenia: proportion of patients who have weight gain as a side effect.
Source(s)
Indicators in The Danish National Indicator Project, schizophrenia. Denmark: The Danish National Indicator Project (DNIP); 7 p.

Measure Domain

Primary Measure Domain
Clinical Quality Measures: Outcome
Secondary Measure Domain
Does not apply to this measure

Brief Abstract

Description

This measure is used to assess the proportion of patients with schizophrenia who have weight gain as a side effect.

Rationale

Antipsychotics belong to a group of drugs frequently associated with side effects. Side effects may occur spontaneously or after months or years of administration. The incidence of side effects has great influence on compliance. It is important that doctor and patient together adjust the treatment and through this reduce the number of side effects.

Evidence for Rationale
Indicators in The Danish National Indicator Project, schizophrenia. Denmark: The Danish National Indicator Project (DNIP); 7 p.
Primary Health Components

Schizophrenia; antipsychotic medication; weight gain

Denominator Description

Patients greater than or equal to 18 years with the diagnosis of schizophrenia within 12 months of contact

Numerator Description

Patients with weight gain as a side effect

Evidence Supporting the Measure

Type of Evidence Supporting the Criterion of Quality for the Measure
  • A formal consensus procedure, involving experts in relevant clinical, methodological, public health and organizational sciences
Additional Information Supporting Need for the Measure

Unspecified

Extent of Measure Testing

Inter-rater reliability has been examined in validation studies, by record review of randomly selected medical records. Completeness of data registration and completeness of inclusion of all the relevant patients has also been evaluated.

Evidence for Extent of Measure Testing
Mainz J, Krog BR, Bjornshave B, Bartels P. Nationwide continuous quality improvement using clinical indicators: The Danish National Indicator Project. Int J Qual Health Care. 2004 Apr;16 Suppl 1:i45-50. PubMed External Web Site Policy

State of Use of the Measure

State of Use
Current routine use
Current Use
Accreditation
Collaborative inter-organizational quality improvement
Decision-making by consumers about health plan/provider choice
Decision-making by managers about resource allocation
External oversight/Regional, county, or city agencies
External oversight/State government program
Internal quality improvement
National reporting
Quality of care research

Application of the Measure in its Current Use

Measurement Setting
Ambulatory/Office-based Care
Hospital Inpatient
Hospital Outpatient
Professionals Involved in Delivery of Health Services
Physicians
Least Aggregated Level of Services Delivery Addressed
Single Health Care Delivery or Public Health Organizations
Statement of Acceptable Minimum Sample Size
Unspecified
Target Population Age

Age greater than or equal to 18 years

Target Population Gender
Either male or female

National Strategy for Quality Improvement in Health Care

National Quality Strategy Aim
Better Care
National Quality Strategy Priority
Prevention and Treatment of Leading Causes of Mortality

Institute of Medicine (IOM) National Health Care Quality Report Categories

IOM Care Need
Living with Illness
IOM Domain
Effectiveness

Data Collection for the Measure

Case Finding Period

Unspecified

Denominator Sampling Frame
Patients associated with provider
Denominator (Index) Event or Characteristic
Clinical Condition
Patient/Individual (Consumer) Characteristic
Denominator Time Window
Does not apply to this measure
Denominator Inclusions/Exclusions

Inclusions
Patients greater than or equal to 18 years with the diagnosis of schizophrenia within 12 months of contact

Note: Based on information from each individual registration of patients medicated with antipsychotic medication leads to patients only included one time irrespective of number of contact with the hospital.

Exclusions
Patients with missing information on questions pertaining to this indicator

Exclusions/Exceptions
Unspecified
Numerator Inclusions/Exclusions

Inclusions
Patients with weight gain as a side effect

Exclusions
Unspecified
Numerator Search Strategy
Episode of care
Data Source
Paper medical record
Region, county, or city public health data
Type of Health State
Adverse Health State
Instruments Used and/or Associated with the Measure

Unspecified

Computation of the Measure

Measure Specifies Disaggregation
Does not apply to this measure
Scoring
Rate/Proportion
Interpretation of Score
Desired value is a lower score
Allowance for Patient or Population Factors
Unspecified
Standard of Comparison
External comparison at a point in, or interval of, time
Internal time comparison

Identifying Information

Original Title

Indicator 6: proportion of patients with schizophrenia who have weight gain as a side effect.

Measure Collection Name
Submitter
The Danish National Schizophrenia Registry - National Government Agency [Non-U.S.]
Developer
The Danish National Schizophrenia Registry - National Government Agency [Non-U.S.]
Funding Source(s)

Danish Regions

Composition of the Group that Developed the Measure

The steering committee for The Danish National Schizophrenia Database (Adult)

  • Merete Nordentoft, MD, professor, lead consultant, PhD, Psychiatric Centre, Bispebjerg (chairperson); Danish Psychiatric Society
  • Inge Voldsgaard, head nurse, Master of Science in Nursing, Department S, Aarhus University Hospital, Risskov (chairperson); Professional Association of Psychiatric Nurses
  • Jeanett Bauer, MD, lead consultant, PhD, Psychiatric Centre, Copenhagen, Danish Psychiatric Society
  • Anne Lindhardt, MD, medical director, Psychiatric Centre Copenhagen, Mental Health Services, the Capital Region of Denmark; Danish Psychiatric Society
  • Anne Sigsgaard, charge nurse, Community Psychiatric Centre, Odense; Professional Association of Psychiatric Nurses
  • Torben Østergaard Christensen, psychologist, specialist in psychopathology, PhD, OPUS, Aalborg; Danish Psychological Association
  • Lars Ahlstrand, senior medical social worker, Psychiatric Centre, Glostrup; Danish Association of Social Workers
  • Kim Johansen, occupational therapist, clinical instructor, Psychiatric Occupational Therapy Department, Frederiksberg Hospital; Danish Association of Occupational Therapists
  • Jan Mainz, MD, professor, senior lead consultant, PhD, Mental Health Services in the North Denmark Region, Aalborg; Danish Psychiatric Society
  • Anne Grethe Viuff, MD, lead consultant, Regional Mental Health Services, Herning; Danish Psychiatric Society
  • Ulrik Haahr, MD, lead consultant, associate professor, Competence Centre for First-episode Psychosis, Mental Health Services, Roskilde; Danish Psychiatric Society
  • Jette Kristine Christensen, clinical development nurse, MHs in Sociology, North Denmark Region, Aalborg; Professional Association of Psychiatric Nurses
  • Kristian Øllegaard Andersen, MD, PhD, OPUS, Region Of Southern Denmark; Danish Psychiatric Society
  • Anders Meinert, MD, MPM, Medical Director, The Psychiatry in Region of Southern Denmark
  • Lone Baandrup, MD, PhD, documentalist; Psychiatric Centre, Glostrup
  • Charlotte Cerqueira, MD, PhD, clinical epidemiologist; Competence Centre for Epidemiology and Biostatistics East; Glostrup Hospital (clinical epidemiologist)
  • Lea Gray Haller, MHsC, Quality Consultant, Competence Centre for Clinical Quality and Health Informatics West (contact person)
  • Hans Peter Graversen, Head of Department, Health — Quality and Informatics, Central Denmark Region (local authority responsible for data)
Financial Disclosures/Other Potential Conflicts of Interest

None

Adaptation

This measure was not adapted from another source.

Date of Most Current Version in NQMC
2010 May
Measure Maintenance

Unspecified

Date of Next Anticipated Revision

Unspecified

Measure Status

This is the current release of the measure.

The measure developer reaffirmed the currency of this measure in November 2013.

Source(s)
Indicators in The Danish National Indicator Project, schizophrenia. Denmark: The Danish National Indicator Project (DNIP); 7 p.
Measure Availability

The individual measure, "Indicator 6: Proportion of Patients with Schizophrenia Who Have Weight Gain as a Side Effect," is published in the "Indicators in The Danish National Indicator Project, Schizophrenia."

For more information, please visit The Danish National Indicator Project Web site External Web Site Policy.

Companion Documents

The following is available:

  • Manual for the development of disease-specific quality indicators, standards and prognostic factors under The Danish National Indicator Project. Version 3.0. Arhus N: The Danish National Indicator Project (DNIP); 2009 Jun. 31 p.
NQMC Status

This NQMC summary was completed by ECRI Institute on May 19, 2010. The information was verified by the measure developer on July 1, 2010. This NQMC summary was retrofitted into the new template on June 14, 2011. The information was reaffirmed by the measure developer on November 8, 2013.

Copyright Statement

No copyright restrictions apply.

Disclaimer

NQMC Disclaimer

The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.

Read full disclaimer...